FBIOX quote
62.78up +0.40 +0.64%
Previous Close62.38CategoryHealth
Net Assets979.68 MilDividend Yield0.00%
Morningstar ratings:Minimum Initial Purchase2,500
RiskAbove Average1 Year ReturnNA
RatingRating: 2 out of 53 Year ReturnNA
ReturnBelow Average5 Year ReturnNA
Cumulative growth of a $10,000 investment
10k growth chart
20042005200620072008YTD
Growth11.99%21.80%26.17%29.51%14.80%29.02%
Value$11,199$12,180$12,617$12,951$11,480$12,902
Last NAV update 11/24/2009 8:00 PM ET   Financial data in U.S. dollars

Your latest quotes:  SAA, FBIOX, IYM, $NWX.X, GPOVY, RSX

Overview
The investment seeks capital appreciation. The fund normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology. These companies may include, companies involved in the research, development, or production of pharmaceuticals, including veterinary drugs. It may invest in securities of foreign issuers. The fund is nondiversified.
More information for FBIOX
Fees and expenses
Front load0.00%
Deferred load0.00%
Expense Ratio0.89%
Top holdings for FBIOX
Company Name% Net Assets
Amgen, Inc.20.33%
Biogen Idec, Inc.9.44%
Alexion Pharmaceuticals, Inc.5.53%
United Therapeutics Corporation5.00%
Vertex Pharmaceuticals4.91%
More top holdings for FBIOX
Additional Fund Information
Inception date12/16/1985
ManagerRajiv Kaul
Manager start date10/12/2005
advertisement
Market update 10:53pm ET

7 things to ask before buying a stock

Putting your money in the market can leave you open to some nasty surprises. Avoid them by doing the right research.

More market news
advertisement


Page generated 1:53 AM Eastern Time